par Rossi, Maxime ;Piagnerelli, Michaël ;Van Meerhaeghe, Alain ;Zouaoui Boudjeltia, Karim
Référence Medical hypotheses, 144, page (110242)
Publication Publié, 2020-11-01
Référence Medical hypotheses, 144, page (110242)
Publication Publié, 2020-11-01
Article révisé par les pairs
Titre: |
|
Auteur: | Rossi, Maxime; Piagnerelli, Michaël; Van Meerhaeghe, Alain; Zouaoui Boudjeltia, Karim |
Informations sur la publication: | Medical hypotheses, 144, page (110242) |
Statut de publication: | Publié, 2020-11-01 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | Acute respiratory distress syndrome (ARDS) |
COVID-19 | |
Cytokine storm | |
Hemin | |
SARS-CoV-2 | |
heme oxygenase-1 (HO-1) | |
MeSH keywords: | Animals |
Anti-Inflammatory Agents -- therapeutic use | |
Antibodies, Monoclonal, Humanized -- therapeutic use | |
COVID-19 -- drug therapy -- metabolism | |
COVID-19 Vaccines | |
Critical Care | |
Cytokine Release Syndrome -- drug therapy -- prevention & control | |
Cytokines -- metabolism | |
Heme Oxygenase-1 -- metabolism | |
Hemin -- metabolism | |
Humans | |
Inflammation | |
Interleukin-6 -- metabolism | |
Models, Theoretical | |
Polymorphism, Genetic | |
Respiratory Distress Syndrome -- physiopathology -- virology | |
Langue: | Anglais |
Identificateurs: | urn:issn:0306-9877 |
info:doi/10.1016/j.mehy.2020.110242 | |
info:pii/S0306-9877(20)31600-5 | |
info:pmid/33254548 | |
PMC7467863 |